Jérôme Robert1, Marc Lehner, Saša Frank, Damir Perisa, Arnold von Eckardstein, Lucia Rohrer. 1. From the Institute of Clinical Chemistry, University Hospital of Zurich, Zurich, Switzerland (J.R., M.L., D.P., A.v.E., L.R.); Zurich Center of Integrated Human Physiology, University of Zurich, Zurich, Switzerland (J.R., D.P., A.v.E., L.R.); and Institute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz, Graz, Austria (S.F.).
Abstract
OBJECTIVE: In the reverse cholesterol transport pathway, high-density lipoprotein (HDL) passes the endothelial cell barrier by mechanisms involving the scavenger receptor class B type I and the ATP-binding cassette G1. However, little is known on how inflammation influences this transendothelial transport. APPROACH AND RESULTS: On stimulation with interleukin-6, cultivated primary endothelial cells showed increased binding and transport of (125)I-HDL without changing the expression of scavenger receptor class B type I and ATP-binding cassette G1. Therefore, we analyzed the involvement of endothelial lipase (EL), a known HDL-binding protein expressed by endothelial cells. Here, we show an increased EL expression after interleukin-6 stimulation. Moreover, using pharmacological inhibitors or RNA interference against EL, we demonstrated its participation in HDL binding and transport through the endothelium. Furthermore, adenovirus-mediated transfection of endothelial cells with either catalytically active or nonactive EL revealed that EL facilitates the endothelial binding and transport by both bridging and lipolysis of HDL. EL was also found responsible for the reduction of HDL particle size occurring during the specific transport through a monolayer of endothelial cells. Finally, pharmacological inhibition of EL reversed the inducing effect of interleukin-6 on HDL binding and transport. CONCLUSIONS: Interleukin-6 stimulates the translocation of HDL through the endothelium, the first step in reverse cholesterol transport pathway, by enhancing EL expression. In addition, we demonstrated the role of EL in the transendothelial transport of HDL.
OBJECTIVE: In the reverse cholesterol transport pathway, high-density lipoprotein (HDL) passes the endothelial cell barrier by mechanisms involving the scavenger receptor class B type I and the ATP-binding cassette G1. However, little is known on how inflammation influences this transendothelial transport. APPROACH AND RESULTS: On stimulation with interleukin-6, cultivated primary endothelial cells showed increased binding and transport of (125)I-HDL without changing the expression of scavenger receptor class B type I and ATP-binding cassette G1. Therefore, we analyzed the involvement of endothelial lipase (EL), a known HDL-binding protein expressed by endothelial cells. Here, we show an increased EL expression after interleukin-6 stimulation. Moreover, using pharmacological inhibitors or RNA interference against EL, we demonstrated its participation in HDL binding and transport through the endothelium. Furthermore, adenovirus-mediated transfection of endothelial cells with either catalytically active or nonactive EL revealed that EL facilitates the endothelial binding and transport by both bridging and lipolysis of HDL. EL was also found responsible for the reduction of HDL particle size occurring during the specific transport through a monolayer of endothelial cells. Finally, pharmacological inhibition of EL reversed the inducing effect of interleukin-6 on HDL binding and transport. CONCLUSIONS:Interleukin-6 stimulates the translocation of HDL through the endothelium, the first step in reverse cholesterol transport pathway, by enhancing EL expression. In addition, we demonstrated the role of EL in the transendothelial transport of HDL.
Authors: Srividya Velagapudi; Lucia Rohrer; Francesco Poti; Jerzy-Roch Nofer; Arnold von Eckardstein; Renate Feuerborn; Damir Perisa; Dongdong Wang; Grigorios Panteloglou; Anton Potapenko; Mustafa Yalcinkaya; Andreas J Hülsmeier; Bettina Hesse; Alexander Lukasz; Mingxia Liu; John S Parks; Christina Christoffersen; Markus Stoffel; Manuela Simoni Journal: Arterioscler Thromb Vasc Biol Date: 2021-08-19 Impact factor: 10.514
Authors: Johanna Apro; Uwe J F Tietge; Arne Dikkers; Paolo Parini; Bo Angelin; Mats Rudling Journal: Arterioscler Thromb Vasc Biol Date: 2016-03-31 Impact factor: 8.311